News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,601 Results
Type
Article (15354)
Company Profile (116)
Press Release (363131)
Section
Business (116572)
Career Advice (468)
Deals (19504)
Drug Delivery (28)
Drug Development (33739)
Employer Resources (49)
FDA (9147)
Job Trends (7902)
News (180753)
Policy (13175)
Tag
Academia (1384)
Alliances (35789)
Alzheimer's disease (502)
Approvals (9162)
Artificial intelligence (211)
Bankruptcy (140)
Best Places to Work (6696)
Biotechnology (87)
Breast cancer (104)
Cancer (879)
Cardiovascular disease (76)
Career advice (416)
CAR-T (91)
Cell therapy (244)
Clinical research (26549)
Collaboration (520)
Compensation (94)
COVID-19 (1217)
C-suite (109)
Data (857)
Diabetes (91)
Diagnostics (4930)
Earnings (39899)
Events (53063)
Executive appointments (348)
FDA (9659)
Funding (415)
Gene editing (71)
Gene therapy (152)
GLP-1 (223)
Government (1341)
Healthcare (10417)
Infectious disease (1288)
IPO (8273)
Job creations (1499)
Job search strategy (371)
Layoffs (120)
Legal (2673)
Lung cancer (108)
Manufacturing (156)
Medical device (11622)
Medtech (11627)
Mergers & acquisitions (11503)
Metabolic disorders (198)
Neuroscience (670)
NextGen: Class of 2025 (3614)
Non-profit (1623)
Northern California (1020)
Obesity (88)
Opinion (77)
Patents (116)
People (33732)
Phase I (9429)
Phase II (11837)
Phase III (8051)
Pipeline (396)
Postmarket research (688)
Preclinical (4234)
Radiopharmaceuticals (156)
Rare diseases (127)
Real estate (3481)
Regulatory (9872)
Research institute (1347)
Resumes & cover letters (69)
Series A (78)
Southern California (1040)
Startups (2552)
United States (10209)
Vaccines (310)
Date
Today (108)
Last 7 days (448)
Last 30 days (1530)
Last 365 days (18968)
2025 (3066)
2024 (19498)
2023 (22959)
2022 (32066)
2021 (33844)
2020 (31633)
2019 (26608)
2018 (20087)
2017 (19562)
2016 (18370)
2015 (21246)
2014 (15836)
2013 (13303)
2012 (14442)
2011 (14846)
2010 (13717)
Location
Africa (340)
Arizona (112)
Asia (24430)
Australia (4251)
California (2548)
Canada (970)
China (203)
Colorado (147)
Connecticut (124)
Europe (54106)
Florida (407)
Georgia (117)
Illinois (255)
Indiana (149)
Japan (92)
Kansas (80)
Maryland (418)
Massachusetts (1788)
Michigan (175)
Minnesota (228)
New Jersey (790)
New York (732)
North Carolina (501)
Northern California (1020)
Ohio (97)
Pennsylvania (512)
South America (620)
Southern California (1040)
Texas (399)
Utah (94)
Washington State (294)
378,601 Results for "cardiologs technologies sas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anumana Joins the American College of Cardiology to Advance AI-Powered Solutions for Detecting Heart Failure
December 12, 2024
·
3 min read
Lone Star Bio
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
Autonomix Medical, Inc. announced that it has regained exclusive worldwide rights to its technology for cardiology field use from Impulse Medical, Inc.
January 30, 2024
·
4 min read
Biotech Beach
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
egnite, Inc., a leading digital health company for cardiovascular care, and JenaValve Technology, Inc., a developer and manufacturer of differentiated transcatheter aortic valve replacement systems, unveil a novel study presented at the American College of Cardiology’s Annual Scientific Session & Expo.
April 6, 2024
·
4 min read
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American College of Cardiology (ACC.24) at the Georgia World Congress Center in Atlanta, GA, April 6 – 8, 2024.
April 1, 2024
·
3 min read
Press Releases
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
February 28, 2025
·
4 min read
Press Releases
Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024
October 31, 2024
·
2 min read
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
Press Releases
Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025
February 21, 2025
·
3 min read
CARDIO inCode-Score (CIC-Score) Presentation at the European Society of Cardiology
GENinCode Plc gave details of a presentation by Kaiser Permanente at the European Society of Cardiology (ESC) Preventive Cardiology congress in Athens, Greece, on the ‘Joint consideration of low-density lipoprotein cholesterol (“LDL-C”) and polygenic risk for incident coronary heart disease in a multi-ethnic cohort of 48,881 individuals’ using CARDIO inCode-Score.
May 1, 2024
·
2 min read
Pharm Country
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Amarin Corporation plc (NASDAQ:AMRN) today announced that additional patient subgroup analyses from the landmark REDUCE-IT outcomes trial and mechanistic data on icosapent ethyl (IPE)/eicosapentaenoic acid (EPA) will be presented at the American College of Cardiology’s Annual Scientific Session & Expo, April 6 – 8, 2024 in Atlanta, GA.
March 25, 2024
·
10 min read
1 of 37,861
Next